세계의 의약품 개발제조수탁기관(CDMO) 시장 : 기회와 전략(-2032년)

“Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Global Market Opportunities And Strategies To 2032 ” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharmaceutical contract development and manufacturing organization (CDMO) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Where is the largest and fastest growing market for pharmaceutical contract development and manufacturing organization (CDMO)? How does the market relate to the overall economy, demography, and other similar markets? What forces will shape the market going forward? “The pharmaceutical contract development and manufacturing organization (CDMO) market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical contract development and manufacturing organization (CDMO) market; and compares it with other markets.

The report covers the following chapters:

Introduction And Market Characteristics

Brief introduction to the segmentations covered in the market, definitions and explanations about the pharmaceutical contract development and manufacturing organization (CDMO) market.

Key Trends

Highlights the major trends shaping the global pharmaceutical contract development and manufacturing organization (CDMO) market. This section also highlights likely future developments in the market.

Macro-Economic Scenario

The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on the global and regional markets, providing strategic insights for businesses in the pharmaceutical contract development and manufacturing organization (CDMO) market.

Global Market Size And Growth

Global historic (2017-2022) and forecast (2022-2027, 2032F) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional And Country Analysis

Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region and country.

Market Segmentation

Contains the market values (2017-2022) (2022-2027, 2032F) and analysis for each segment by type, by CMO service, by CRO service and by end user in the market.

Regional Market Size And Growth

Regional market size (2022), historic (2017-2022) and forecast (2022-2027, 2032F) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

Competitive Landscape

Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

Key Mergers And Acquisitions

Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies

Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

Conclusions And Recommendations

This section Includes recommendations for pharmaceutical contract development and manufacturing organization (CDMO) providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.

Appendix

This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

• 1)By Type: Contract Manufacturing Services; Contract Research Services
• a) By CMO Service: Active Pharmaceutical Ingredients (API) Manufacturing; Finished Dosage Formulation (FDF) Development And Manufacturing; Secondary Packaging
• b) By CRO Service: Preclinical; Phase I; Phase II; Phase III; Phase IV
• 2)By End User: Big Pharmaceutical Companies; Generic Pharmaceutical Companies; Small And Medium-Sized Pharmaceutical Companies
• Companies Mentioned: Lonza Group; Catalent Inc; WuXi AppTec Inc.; Pfizer Inc; Recipharm AB
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; Argentina; Chile; Colombia; Peru; France; Germany; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharmaceutical contract development and manufacturing organization (CDMO) indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Table of Contents

1. Executive Summary

2. Table Of Contents

3. List Of Figures

4. List Of Tables

5. Report Structure

6. Introduction And Market Characteristics

• 6.1. General Market Definition
• 6.2. Summary
• 6.3. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market Definition And Segmentations
• 6.4. Market Segmentation By Type
  • 6.4.1. Contract Manufacturing Services
  • 6.4.2. Contract Research Services
• 6.5. Market Segmentation By CMO Service
  • 6.5.1. Active Pharmaceutical Ingredients (API) Manufacturing
  • 6.5.2. Finished Dosage Formulation (FDF) Development And Manufacturing
  • 6.5.3. Secondary Packaging
• 6.6. Market Segmentation By CRO Service
  • 6.6.1. Preclinical
  • 6.6.2. Phase I
  • 6.6.3. Phase II
  • 6.6.4. Phase III
  • 6.6.5. Phase IV
• 6.7. Market Segmentation By End User
  • 6.7.1. Big Pharmaceutical Companies
  • 6.7.2. Small And Medium-Sized Pharmaceutical Companies

7. Pharmaceutical Contract Development And Manufacturing Organization Market - Macro-Economic Scenario

• 7.1. COVID-19 Impact On The Pharmaceutical Contract Development And Manufacturing Organization Market
• 7.2. Russia-Ukraine War Impact On The Pharmaceutical Contract Development And Manufacturing Organization Market
• 7.3. Impact Of High Inflation On The Pharmaceutical Contract Development And Manufacturing Organization Market

8. Major Market Trends

• 8.1. Increased Focus on Sustainability
• 8.2. Focus On Integration Of Artificial Intelligence and Digitalization
• 8.3. Innovative Products With Focus On Resilience
• 8.4. Increasing Investments
• 8.5. Strategic Partnerships and Collaborations Among Market Players

9. Global Market Size and Growth

• 9.1. Market Size
• 9.2. Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 9.2.1. Market Drivers 2017 - 2022
  • 9.2.2. Market Restraints 2017 - 2022
• 9.3. Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 9.3.1. Market Drivers 2022 - 2027
  • 9.3.2. Market Restraints 2022 - 2027

10. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market Segmentation

• 10.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 10.1.1. Global Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 10.1.2. Global Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 10.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

11. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Regional and Country Analysis

• 11.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, By Region, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 11.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, By Country, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

12. Asia-Pacific Market

• 12.1. Summary
• 12.2. Market Overview
  • 12.2.1. Region Information
  • 12.2.2. Market Information
  • 12.2.3. Background Information
  • 12.2.4. Government Initiatives
  • 12.2.5. Regulations
  • 12.2.6. Regulatory Bodies
  • 12.2.7. Major Associations
  • 12.2.8. Taxes Levied
  • 12.2.9. Corporate Tax Structure
  • 12.2.10. Investments
  • 12.2.11. Major Companies
• 12.3. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.4. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.5. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.5.1. Asia-Pacific Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.5.2. Asia-Pacific Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.6. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.7. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market: Country Analysis
• 12.8. China Market
• 12.9. Summary
• 12.10. Market Overview
  • 12.10.1. Country Information
  • 12.10.2. Market Information
  • 12.10.3. Background Information
  • 12.10.4. Government Initiatives
  • 12.10.5. Regulations
  • 12.10.6. Regulatory Bodies
  • 12.10.7. Major Associations
  • 12.10.8. Taxes Levied
  • 12.10.9. Corporate Tax Structure
  • 12.10.10. Investments
  • 12.10.11. Major Companies
• 12.11. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.12. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.13. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.13.1. China Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.13.2. China Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.14. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.15. India Market
• 12.16. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.17. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.18. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.18.1. India Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.18.2. India Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.19. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.20. Japan Market
• 12.21. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.22. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.23. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.23.1. Japan Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.23.2. Japan Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.24. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.25. Australia Market
• 12.26. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.27. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.28. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.28.1. Australia Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.28.2. Australia Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.29. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.30. Indonesia Market
• 12.31. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.32. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.33. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.33.1. Indonesia Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.33.2. Indonesia Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.34. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.35. South Korea Market
• 12.36. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 12.37. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 12.38. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.38.1. South Korea Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.38.2. South Korea Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 12.39. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

13. Western Europe Market

• 13.1. Summary
• 13.2. Market Overview
  • 13.2.1. Region Information
  • 13.2.2. Market Information
  • 13.2.3. Background Information
  • 13.2.4. Government Initiatives
  • 13.2.5. Regulations
  • 13.2.6. Regulatory Bodies
  • 13.2.7. Major Associations
  • 13.2.8. Taxes Levied
  • 13.2.9. Corporate Tax Structure
  • 13.2.10. Investments
  • 13.2.11. Major Companies
• 13.3. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 13.4. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 13.5. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.5.1. Western Europe Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.5.2. Western Europe Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.6. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.7. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market: Country Analysis
• 13.8. UK Market
• 13.9. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 13.10. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 13.11. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.11.1. UK Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.11.2. UK Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.12. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.13. Germany Market
• 13.14. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 13.15. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 13.16. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.16.1. Germany Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.16.2. Germany Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.17. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.18. France Market
• 13.19. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 13.20. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 13.21. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.21.1. France Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.21.2. France Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 13.22. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

14. Eastern Europe Market

• 14.1. Summary
• 14.2. Market Overview
  • 14.2.1. Region Information
  • 14.2.2. Market Information
  • 14.2.3. Background Information
  • 14.2.4. Government Initiatives
  • 14.2.5. Regulations
  • 14.2.6. Regulatory Bodies
  • 14.2.7. Major Associations
  • 14.2.8. Taxes Levied
  • 14.2.9. Corporate Tax Structure
  • 14.2.10. Investments
  • 14.2.11. Major Companies
• 14.3. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 14.4. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 14.5. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.5.1. Eastern Europe Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.5.2. Eastern Europe Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 14.6. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 14.7. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market: Country Analysis
• 14.8. Russia Market
• 14.9. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 14.10. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 14.11. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.11.1. Russia Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.11.2. Russia Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 14.12. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

15. North America Market

• 15.1. Summary
• 15.2. Market Overview
  • 15.2.1. Region Information
  • 15.2.2. Market Information
  • 15.2.3. Background Information
  • 15.2.4. Government Initiatives
  • 15.2.5. Regulations
  • 15.2.6. Regulatory Bodies
  • 15.2.7. Major Associations
  • 15.2.8. Taxes Levied
  • 15.2.9. Corporate Tax Structure
  • 15.2.10. Investments
  • 15.2.11. Major Companies
• 15.3. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 15.4. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 15.5. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.5.1. North America Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.5.2. North America Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 15.6. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 15.7. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market: Country Analysis
• 15.8. USA Market
• 15.9. Summary
• 15.10. Market Overview
  • 15.10.1. Country Information
  • 15.10.2. Market Information
  • 15.10.3. Background Information
  • 15.10.4. Government Initiatives
  • 15.10.5. Regulations
  • 15.10.6. Regulatory Bodies
  • 15.10.7. Major Associations
  • 15.10.8. Taxes Levied
  • 15.10.9. Corporate Tax Structure
  • 15.10.10. Investments
  • 15.10.11. Major Companies
• 15.11. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 15.12. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 15.13. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.13.1. USA Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.13.2. USA Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 15.14. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

16. South America Market

• 16.1. Summary
• 16.2. Market Overview
  • 16.2.1. Region Information
  • 16.2.2. Market Information
  • 16.2.3. Background Information
  • 16.2.4. Government Initiatives
  • 16.2.5. Regulations
  • 16.2.6. Regulatory Bodies
  • 16.2.7. Major Associations
  • 16.2.8. Taxes Levied
  • 16.2.9. Corporate Tax Structure
  • 16.2.10. Investment
  • 16.2.11. Major Companies
• 16.3. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 16.4. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 16.5. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.5.1. South America Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.5.2. South America Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.6. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.7. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market: Country Analysis
• 16.8. Argentina Market
• 16.9. Argentina Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 16.10. Argentina Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 16.11. Argentina Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.11.1. Argentina Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.11.2. Argentina Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.12. Argentina Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.13. Brazil Market
• 16.14. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 16.15. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 16.16. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.16.1. Brazil Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.16.2. Brazil Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.17. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.18. Chile Market
• 16.19. Chile Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 16.20. Chile Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 16.21. Chile Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.21.1. Chile Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.21.2. Chile Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.22. Chile Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.23. Colombia Market
• 16.24. Colombia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 16.25. Colombia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 16.26. Colombia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.26.1. Colombia Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.26.2. Colombia Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.27. Colombia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.28. Peru Market
• 16.29. Peru Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 16.30. Peru Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 16.31. Peru Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.31.1. Peru Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.31.2. Peru Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 16.32. Peru Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

17. Middle East Market

• 17.1. Summary
• 17.2. Market Overview
  • 17.2.1. Region Information
  • 17.2.2. Market Information
  • 17.2.3. Background Information
  • 17.2.4. Government Initiatives
  • 17.2.5. Regulations
  • 17.2.6. Regulatory Bodies
  • 17.2.7. Major Associations
  • 17.2.8. Taxes Levied
  • 17.2.9. Corporate Tax Structure
  • 17.2.10. Investments
  • 17.2.11. Major Companies
• 17.3. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 17.4. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 17.5. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 17.5.1. Middle East Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 17.5.2. Middle East Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 17.6. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

18. Africa Market

• 18.1. Summary
• 18.2. Market Overview
  • 18.2.1. Region Information
  • 18.2.2. Market Information
  • 18.2.3. Background Information
  • 18.2.4. Government Initiatives
  • 18.2.5. Regulations
  • 18.2.6. Regulatory Bodies
  • 18.2.7. Major Associations
  • 18.2.8. Taxes Levied
  • 18.2.9. Corporate Tax Structure
  • 18.2.10. Investments
  • 18.2.11. Major Companies
• 18.3. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
• 18.4. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
• 18.5. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 18.5.1. Africa Contract Manufacturing Services Market, Segmentation By CMO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 18.5.2. Africa Contract Research Services Market, Segmentation By CRO Service, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
• 18.6. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

19. Competitive Landscape and Company Profiles

• 19.1. Company Profiles
• 19.2. Lonza Group
  • 19.2.1. Company Overview
  • 19.2.2. Products And Services
  • 19.2.3. Business Strategy
  • 19.2.4. Financial Overview
• 19.3. Catalent Inc
  • 19.3.1. Company Overview
  • 19.3.2. Products And Services
  • 19.3.3. Business Strategy
  • 19.3.4. Financial Overview
• 19.4. WuXi AppTec Co., Ltd
  • 19.4.1. Company Overview
  • 19.4.2. Products And Services
  • 19.4.3. Business Strategy
  • 19.4.4. Financial Overview
• 19.5. Pfizer Inc
  • 19.5.1. Company Overview
  • 19.5.2. Products And Services
  • 19.5.3. Business Strategy
  • 19.5.4. Financial Overview
• 19.6. Recipharm AB
  • 19.6.1. Company Overview
  • 19.6.2. Products And Services
  • 19.6.3. Business Strategy
  • 19.6.4. Financial Overview

20. Key Mergers And Acquisitions

• 20.1. The Biofarma Group Acquired U.S. Pharma Lab
• 20.2. Catalent Acquired Metrics Contract Services
• 20.3. Astorg And International Chemical Investors Group Acquired CordenPharma
• 20.4. Bora Pharmaceuticals Acquired Eden Biologics
• 20.5. Recipharm Acquired GenIbet
• 20.6. Pharmaron Beijing Co., Ltd Acquired Aesica Pharmaceuticals Limited

21. Opportunities And Strategies

• 21.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market In 2027 - Countries Offering Most New Opportunities
• 21.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market In 2027 - Segments Offering Most New Opportunities
• 21.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market In 2027 - Growth Strategies
  • 21.3.1. Market Trend Based Strategies
  • 21.3.2. Competitor Strategies

22. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Conclusions And Recommendations

• 22.1. Conclusions
• 22.2. Recommendations
  • 22.2.1. Product
  • 22.2.2. Place
  • 22.2.3. Price
  • 22.2.4. Promotion
  • 22.2.5. People

23. Appendix

• 23.1. Market Data Sources
• 23.2. Research Methodology
• 23.3. Currencies
• 23.4. The Business Research Company
• 23.5. Copyright and Disclaimer